China SXT Pharmaceuticals (SXTC) Inventory: 2018-2025
- China SXT Pharmaceuticals' Inventory fell 13.36% to $751,346 in Q3 2025 from the same period last year, while for Sep 2025 it was $751,346, marking a year-over-year decrease of 13.36%. This contributed to the annual value of $828,053 for FY2025, which is 4.18% up from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Inventory of $751,346 as of Q3 2025, which was down 9.26% from $828,053 recorded in Q1 2025.
- China SXT Pharmaceuticals' 5-year Inventory high stood at $1.0 million for Q1 2022, and its period low was $493,214 during Q3 2023.
- Over the past 3 years, China SXT Pharmaceuticals' median Inventory value was $773,100 (recorded in 2024), while the average stood at $710,992.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Inventory plummeted by 47.79% in 2023, and later spiked by 75.83% in 2024.
- Quarterly analysis of 5 years shows China SXT Pharmaceuticals' Inventory stood at $837,447 in 2021, then dropped by 24.99% to $628,186 in 2022, then declined by 21.49% to $493,214 in 2023, then surged by 75.83% to $867,233 in 2024, then declined by 13.36% to $751,346 in 2025.
- Its last three reported values are $751,346 in Q3 2025, $828,053 for Q1 2025, and $867,233 during Q3 2024.
